Skip to main content

Table 5 Comparison of complications induced by TACE therapy between DEB-TACE and cTACE

From: CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study

Complications

DEB-TACE

cTACE

χ2 value

p value

Post-embolization syndrome

15 (62.5%)

26 (81.3%)

4.260

0.039

Transient liver injury

11 (46%)

20 (67%)

2.367

0.124

Liver abscess

1 (4.1%)

0

1.274

0.259

Ascites

3 (13%)

8 (27%)

1.650

0.199

Myelosuppression

1 (4.1%)

9 (30%)

5.897

0.015

Granulocyte reduction

2 (8.3%)

13 (43%)

8.142

0.004